Promoting Excellence in Education, Research,
and Patient Care in the Rapidly Evolving
Management of Gastrointestinal Cancer
International Society of
Gastrointestinal Oncology
isgioEstablished 2003
ISGIO President and President-elect
ISGIO President
Dr. Axel Grothey
Dr. Axel Grothey
Dr. Axel Grothey
Mayo Clinic

Axel Grothey, M.D., is a consultant in the Division of Medical Oncology, Department of Oncology, at Mayo Clinic. He holds the academic rank of professor of oncology and has teaching/examining privileges in Clinical & Translational Science at Mayo Graduate School. He is a member of Mayo Clinic’s Cancer Center.

Dr. Grothey received his medical degree at Ruhr-Universitat Bochum, Germany, and completed residencies at West-German Tumorcenter and the Institute of Pathology at the University of Essen and a residency and fellowship at the University of Bochum. He also completed a research fellowship at MD Cancer Center at the University of Texas. He joined Mayo Clinic as a consultant in 2005.

Dr. Grothey’s clinical interests focus on gastrointestinal cancers, endocrine tumors, anti-angiogenesis, signal transduction inhibitors, and clinical trial design and statistics. As a consultant and investigator, his research has been funded by the National Cancer Institute (NCI) and the National Institutes of Health, among other organizations. He currently chairs the NCI colon cancer task force, and serves as vice-chair of the gastrointestinal cancer committee of the Alliance for Clinical Trials in Oncology, an NCI-funded cooperative group.

He currently holds professional positions in the Association of German Internists, German Cancer Association, Working Group of Experimental Cancer Research in Germany, American Association for Cancer Research, European Association for Cancer Research, American Society for Cell Biology, MD Anderson Associates, American Society of Clinical Oncology, European Society for Medical Oncology, German Association for Internal Oncology and the Minnesota Medical Association. He also has served in various leadership positions at Mayo Clinic Cancer Center.

ISGIO President-elect 2015-2017
Dr. Howard Hochster
Dr. Howard Hochster
Howard Hochster, MD
Yale School of Medicine

Howard S. Hochster MD, is Associate Cancer Center Director for Clinical Sciences at the Yale Comprehensive Cancer Center and Professor of Medicine at the Yale School of Medicine. He is an active Attending Physician at the Smilow Cancer Hospital and is Director of the GI Oncology Program at the YCCC and Smilow Cancer Hospital.

Dr. Hochster is a well-known international figure in Gastrointestinal Cancer treatment and in developing new drugs to the clinic for these diseases. He has been recognized as on the “Top Oncology Doctors in America” and in the New York area for many years. He has chaired and published numerous clinical trials in the area of cancer drug development. He serves as Principal Investigator for SWOG at Yale and its affiliated institutions, recipient of the Yale U10 grant, and GI Committee Chair for SWOG. He is also an active member of the Colon Task Force and a member of the CTEP GI Steering Committee. He was national director of Early Drug Development for Aptium Oncology Research Network and was a key member of the steering committee of the Aptium GI Cancer Consortium (AGICC). He is a medical director of the Chemotherapy Foundation of NYC and regularly chair the GI sessions at the annual meeting. He reviews grants regularly for NIH, Texas C-PRIT, and Cancer Research UK. He has served on the DSMB for international phase III trials. He has promoted cancer research and practice in New York City as President of the New York Cancer Society from 2005-2007.